Study reveals new AI tool predicts recurrence of prostate cancer by a decade The most commonly diagnosed cancer in men in the UK leads to over 12,000 annual deaths
Royal Marsden launches first UK genome testing facility to improve testing for cancer The installation will double the capacity of cancer genomic testing using robotic automation